Patient Services
Health Information
  Health News Headlines
  Health Topics A-Z
  En Español A-Z
  Quizzes/Calculators
  Glossaries/Printouts
  For Your Heart
  About Cancer
  Women's Topics
  Children & Health
  Senior Health
  Orthopedic Info
  In An Emergency
  Diet & Exercise
Community Health Resource Center
Community Events
Career Opportunities
About Us
Foundation
Press Room


Learn more about the Da Vinci Surgical System


By printing and/or reading this article, you agree that you accept all terms and conditions of use, as specified online.

Common Antibiotic to Get Extra Warnings

In the news...(July 10, 2008) - A relatively common antibiotic group (Read about "Antibiotics") is getting an extra warning added to its label on side effects. Fluoroquinolone antimicrobial drugs have been implicated in an increased risk of tendinitis and tendon rupture. (Read about "Tendinitis & Bursitis")

The medications involved in this action are: Cipro and generic ciprofloxacin, Cipro XR and Proquin XR (ciprofloxacin extended release), Factive (gemifloxacin), Levaquin (levofloxacin), Avelox (moxifloxacin), Noroxin (norfloxacin), and Floxin and generic ofloxacin.

Cipro became well-known as an antibiotic during the anthrax scare a few years ago. (Read about "Biological Health Threats")

"Fluoroquinolones are effective in treating certain bacterial infections, but health care professionals and patients need to be aware of the increased risk associated with the use of these drugs of developing tendinitis and tendon rupture, particularly for certain patient populations," said Edward Cox, M.D., director, Office of Antimicrobial Products, Center for Drug Evaluation and Research.

The U.S. Food and Drug Administration (FDA) says it has conducted a new analysis of the available literature and post-marketing adverse event reports. This new analysis reconfirms that use of fluoroquinolones is associated with an increased risk of tendon rupture. It also demonstrates that despite the current warning of tendon rupture in the labeling for the fluoroquinolones, large numbers of tendon-related adverse events continue to be reported.

FDA says the risk of developing fluoroquinolone-associated tendinitis and tendon rupture is further increased in people older than 60, in those taking corticosteroid drugs, and in kidney, heart, and lung transplant recipients. (Read about "Transplants") Patients experiencing pain, swelling, inflammation of a tendon or tendon rupture should be advised to stop taking their fluoroquinolone medication and to contact their healthcare professional promptly about changing their antimicrobial therapy. Patients should also avoid exercise and using the affected area at the first sign of tendon pain, swelling or inflammation.

Note: Statements and conclusions of study authors that are published here are solely those of the study authors and do not necessarily reflect this hospital's policy or position. This hospital makes no representation or warranty as to their accuracy or reliability.

All Concept Communications material is provided for information only and is neither advice nor a substitute for proper medical care. Consult a qualified healthcare professional who understands your particular history for individual concerns.

© Concept Communications Media Group LLC

Online health topics reviewed/modified in 2008 | Terms of Use/Privacy Policy

By printing and/or reading this article, you agree that you accept all terms and conditions of use, as specified online.